Autophagy is involved in neurofibromatosis type I gene‑modulated osteogenic differentiation in human bone mesenchymal stem cells

Li,Yiqiang; Zhu,Mingwei; Lin,Xuemei; Li,Jingchun; Yuan,Zhe; Liu,Yanhan; Xu,Hongwen

doi:10.3892/etm.2021.10697

Autophagy is involved in neurofibromatosis type I gene‑modulated osteogenic differentiation in human bone mesenchymal stem cells

Authors:
- Yiqiang Li
- Mingwei Zhu
- Xuemei Lin
- Jingchun Li
- Zhe Yuan
- Yanhan Liu
- Hongwen Xu
View Affiliations

Affiliations: Department of Pediatric Orthopedics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong 510623, P.R. China
Published online on: September 6, 2021 https://doi.org/10.3892/etm.2021.10697
Article Number: 1262
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Neurofibromatosis type I (NF1) is an autosomal dominant genetic disease that is caused by mutations in the NF1 gene. Various studies have previously demonstrated that the mTOR complex 1 signaling pathway is essential for the NF1‑modulated osteogenic differentiation of bone mesenchymal stem cells (BMSCs). Additionally, the mTOR signaling pathway plays a notable role in autophagy. The present study hypothesized that NF1 could modulate the osteogenic differentiation of BMSCs by regulating the autophagic activities of BMSCs. In the present study, human BMSCs were cultured in an osteogenic induction medium. The expression of the NF1 gene was either knocked down or overexpressed by transfection with a specific small interfering RNA (siRNA) targeting NF1 or the pcDNA3.0 NF1‑overexpression plasmid, respectively. Autophagic activities of BMSCs (Beclin‑1, P62, LC3B I, and LC3B II) were determined using western blotting, electron microscopy, acridine orange (AO) staining and autophagic flux/lysosomal detection by fluorescence microscopy. In addition, the autophagy activator rapamycin (RAPA) and inhibitor 3‑methyladenine (3‑MA) were used to investigate the effects of autophagy on NF1‑modulated osteogenic differentiation in BMSCs. Inhibiting NF1 with siRNA significantly decreased the expression levels of autophagy markers Beclin‑1 and LC3B‑II, in addition to osteogenic differentiation markers osterix, runt‑related transcription factor 2 and alkaline phosphatase. By contrast, overexpressing NF1 with pcDNA3.0 significantly increased their levels. Transmission electron microscopy, AO staining and autophagic flux/lysosomal detection assays revealed that the extent of autophagosome formation was significantly decreased in the NF1‑siRNA group but significantly increased in the NF1‑pcDNA3.0 group when compared with the NC‑siRNA and pcDNA3.0 groups, respectively. In addition, the activity of the PI3K/AKT/mTOR pathway [phosphorylated (p)‑PI3K, p‑AKT, p‑mTOR and p‑p70S6 kinase] was significantly upregulated in the NF1‑siRNA group compared with the NC‑siRNA group, and significantly inhibited in the NF1‑pcDNA3.0 group, compared with the pcDNA3.0 group. The knockdown effects of NF1‑siRNA on the autophagy and osteogenic differentiation of BMSCs were reversed by the autophagy activator RAPA, while the overexpression effects of NF1‑pcDNA3.0 on the autophagy and osteogenic differentiation of BMSCs were reversed by the autophagy inhibitor 3‑MA. In conclusion, results from the present study suggest at the involvement of autophagy in the NF1‑modulated osteogenic differentiation of BMSCs. Furthermore, NF1 may partially regulate the autophagic activity of BMSCs through the PI3K/AKT/mTOR signaling pathway.

View Figures

View References

1	Anderson JL and Gutmann DH: Neurofibromatosis type 1. Handb Clin Neurol. 132:75–86. 2015.PubMed/NCBI View Article : Google Scholar
2	Ferner RE and Gutmann DH: Neurofibromatosis type 1 (NF1): Diagnosis and management. Handb Clin Neurol. 115:939–955. 2013.PubMed/NCBI View Article : Google Scholar
3	Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL and Johnson KJ: Neurofibromatosis type 1. Nat Rev Dis Primers. 3(17004)2017.PubMed/NCBI View Article : Google Scholar
4	Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, Upadhyaya M, Towers R, Gleeson M, Steiger C and Kirby A: Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet. 44:81–88. 2007.PubMed/NCBI View Article : Google Scholar
5	Feldman DS, Jordan C and Fonseca L: Orthopaedic manifestations of neurofibromatosis type 1. J Am Acad Orthop Surg. 18:346–357. 2010.PubMed/NCBI View Article : Google Scholar
6	Vitale MG, Guha A and Skaggs DL: Orthopaedic manifestations of neurofibromatosis in children: An update. Clin Orthop Relat Res. 107–118. 2002.PubMed/NCBI View Article : Google Scholar
7	Shen MH, Harper PS and Upadhyaya M: Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet. 33:2–17. 1996.PubMed/NCBI View Article : Google Scholar
8	Leskelä HV, Kuorilehto T, Risteli J, Koivunen J, Nissinen M, Peltonen S, Kinnunen P, Messiaen L, Lehenkari P and Peltonen J: Congenital pseudarthrosis of neurofibromatosis type 1: Impaired osteoblast differentiation and function and altered NF1 gene expression. Bone. 44:243–250. 2009.PubMed/NCBI View Article : Google Scholar
9	Sharma R, Wu X, Rhodes SD, Chen S, He Y, Yuan J, Li J, Yang X, Li X, Jiang L, et al: Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice. Hum Mol Genet. 22:4818–4828. 2013.PubMed/NCBI View Article : Google Scholar
10	Kolanczyk M, Kossler N, Kuhnisch J, Lavitas L, Stricker S, Wilkening U, Manjubala I, Fratzl P, Sporle R, Herrmann BG, et al: Multiple roles for neurofibromin in skeletal development and growth. Hum Mol Genet. 16:874–886. 2007.PubMed/NCBI View Article : Google Scholar
11	Wu X, Estwick SA, Chen S, Yu M, Ming W, Nebesio TD, Li Y, Yuan J, Kapur R, Ingram D, et al: Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem/progenitor cells. Hum Mol Genet. 15:2837–2845. 2006.PubMed/NCBI View Article : Google Scholar
12	Wang W, Nyman JS, Ono K, Stevenson DA, Yang X and Elefteriou F: Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I. Hum Mol Genet. 20:3910–3924. 2011.PubMed/NCBI View Article : Google Scholar
13	Li Y, Li J, Zhou Q, Liu Y, Chen W and Xu H: mTORC1 signaling is essential for neurofibromatosis type I gene modulated osteogenic differentiation of BMSCs. J Cell Biochem. 120:2886–2896. 2019.PubMed/NCBI View Article : Google Scholar
14	Reggiori F and Klionsky DJ: Autophagy in the eukaryotic cell. Eukaryot Cell. 1:11–21. 2002.PubMed/NCBI View Article : Google Scholar
15	Wan Y, Zhuo N, Li Y, Zhao W and Jiang D: Autophagy promotes osteogenic differentiation of human bone marrow mesenchymal stem cell derived from osteoporotic vertebrae. Biochem Biophys Res Commun. 488:46–52. 2017.PubMed/NCBI View Article : Google Scholar
16	Zhou Z, Shi G, Zheng X, Jiang S and Jiang L: Autophagy activation facilitates mechanical stimulation-promoted osteoblast differentiation and ameliorates hindlimb unloading-induced bone loss. Biochem Biophys Res Commun. 498:667–673. 2018.PubMed/NCBI View Article : Google Scholar
17	Lim HJ, Crowe P and Yang JL: Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer. J Cancer Res Clin Oncol. 141:671–689. 2015.PubMed/NCBI View Article : Google Scholar
18	Heras-Sandoval D, Perez-Rojas JM, Hernandez-Damian J and Pedraza-Chaverri J: The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell Signal. 26:2694–2701. 2014.PubMed/NCBI View Article : Google Scholar
19	Rabanal-Ruiz Y, Otten EG and Korolchuk VI: mTORC1 as the main gateway to autophagy. Essays Biochem. 61:565–584. 2017.PubMed/NCBI View Article : Google Scholar
20	Tan Q, Wu JY, Liu YX, Liu K, Tang J, Ye WH, Zhu GH, Mei HB and Yang G: The neurofibromatosis type I gene promotes autophagy via mTORC1 signalling pathway to enhance new bone formation after fracture. J Cell Mol Med. 24:11524–11534. 2020.PubMed/NCBI View Article : Google Scholar
21	Zhao F, Feng G, Zhu J, Su Z, Guo R, Liu J, Zhang H and Zhai Y: 3-Methyladenine-enhanced susceptibility to sorafenib in hepatocellular carcinoma cells by inhibiting autophagy. Anticancer Drugs. 32:386–393. 2021.PubMed/NCBI View Article : Google Scholar
22	Song C, Song C and Tong F: Autophagy induction is a survival response against oxidative stress in bone marrow-derived mesenchymal stromal cells. Cytotherapy. 16:1361–1370. 2014.PubMed/NCBI View Article : Google Scholar
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
24	Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, et al: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 12:1–222. 2016.PubMed/NCBI View Article : Google Scholar
25	Shibutani ST, Saitoh T, Nowag H, Münz C and Yoshimori T: Autophagy and autophagy-related proteins in the immune system. Nat Immunol. 16:1014–1024. 2015.PubMed/NCBI View Article : Google Scholar
26	Yang K, Guo W, Ren T, Huang Y, Han Y, Zhang H and Zhang J: Knockdown of HMGA2 regulates the level of autophagy via interactions between MSI2 and Beclin1 to inhibit NF1-associated malignant peripheral nerve sheath tumour growth. J Exp Clin Cancer Res. 38(185)2019.PubMed/NCBI View Article : Google Scholar
27	Lopez G, Torres K, Liu J, Hernandez B, Young E, Belousov R, Bolshakov S, Lazar AJ, Slopis JM, McCutcheon IE, et al: Autophagic survival in resistance to histone deacetylase inhibitors: Novel strategies to treat malignant peripheral nerve sheath tumors. Cancer Res. 71:185–196. 2011.PubMed/NCBI View Article : Google Scholar
28	de la Croix Ndong J, Stevens DM, Vignaux G, Uppuganti S, Perrien DS, Yang X, Nyman JS, Harth E and Elefteriou F: Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx-/-mice. J Bone Miner Res. 30:55–63. 2015.PubMed/NCBI View Article : Google Scholar
29	Ma Y, Qi M, An Y, Zhang L, Yang R, Doro DH, Liu W and Jin Y: Autophagy controls mesenchymal stem cell properties and senescence during bone aging. Aging Cell. 17(e12709)2018.PubMed/NCBI View Article : Google Scholar
30	Nuschke A, Rodrigues M, Stolz DB, Chu CT, Griffith L and Wells A: Human mesenchymal stem cells/multipotent stromal cells consume accumulated autophagosomes early in differentiation. Stem Cell Res Ther. 5(140)2014.PubMed/NCBI View Article : Google Scholar
31	Liu X, Wang Y, Cao Z, Dou C, Bai Y, Liu C, Dong S and Fei J: Staphylococcal lipoteichoic acid promotes osteogenic differentiation of mouse mesenchymal stem cells by increasing autophagic activity. Biochem Biophys Res Commun. 485:421–426. 2017.PubMed/NCBI View Article : Google Scholar
32	Gomez-Puerto MC, Verhagen LP, Braat AK, Lam EW, Coffer PJ and Lorenowicz MJ: Activation of autophagy by FOXO3 regulates redox homeostasis during osteogenic differentiation. Autophagy. 12:1804–1816. 2016.PubMed/NCBI View Article : Google Scholar
33	Chang H, Li X, Cai Q, Li C, Tian L, Chen J, Xing X, Gan Y, Ouyang W and Yang Z: The PI3K/Akt/mTOR pathway is involved in CVB3-induced autophagy of HeLa cells. Int J Mol Med. 40:182–192. 2017.PubMed/NCBI View Article : Google Scholar
34	Gao Y, Zhang Y and Fan Y: Eupafolin ameliorates lipopolysaccharide-induced cardiomyocyte autophagy via PI3K/AKT/mTOR signaling pathway. Iran J Basic Med Sci. 22:1340–1346. 2019.PubMed/NCBI View Article : Google Scholar
35	Schulte A, Ewald F, Spyra M, Smit DJ, Jiang W, Salamon J, Jucker M and Mautner VF: Combined targeting of AKT and mTOR inhibits proliferation of human NF1-associated malignant peripheral nerve sheath tumour cells in vitro but not in a xenograft mouse model in vivo. Int J Mol Sci. 21(1548)2020.PubMed/NCBI View Article : Google Scholar
36	Li XX, Zhang SJ, Chiu AP, Lo LH, Huang J, Rowlands DK, Wang J and Keng VW: Targeting of AKT/ERK/CTNNB1 by DAW22 as a potential therapeutic compound for malignant peripheral nerve sheath tumor. Cancer Med. 7:4791–4800. 2018.PubMed/NCBI View Article : Google Scholar
37	Kim YC and Guan KL: mTOR: A pharmacologic target for autophagy regulation. J Clin Invest. 125:25–32. 2015.PubMed/NCBI View Article : Google Scholar
38	Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y, Iemura S, Natsume T, Takehana K, Yamada N, et al: Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell. 20:1981–1991. 2009.PubMed/NCBI View Article : Google Scholar
39	Blommaart EF, Krause U, Schellens JP, Vreeling-Sindelarova H and Meijer AJ: The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. Eur J Biochem. 243:240–246. 1997.PubMed/NCBI View Article : Google Scholar
40	Petiot A, Ogier-Denis E, Blommaart EF, Meijer AJ and Codogno P: Distinct classes of phosphatidylinositol 3'-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J Biol Chem. 275:992–998. 2000.PubMed/NCBI View Article : Google Scholar
41	Wu YT, Tan HL, Shui G, Bauvy C, Huang Q, Wenk MR, Ong CN, Codogno P and Shen HM: Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J Biol Chem. 285:10850–10861. 2010.PubMed/NCBI View Article : Google Scholar
42	Li Y, Su J, Sun W, Cai L and Deng Z: AMP-activated protein kinase stimulates osteoblast differentiation and mineralization through autophagy induction. Int J Mol Med. 41:2535–2544. 2018.PubMed/NCBI View Article : Google Scholar
43	Chen X, Sun K, Zhao S, Geng T, Fan X, Sun S, Zheng M and Jin Q: Irisin promotes osteogenic differentiation of bone marrow mesenchymal stem cells by activating autophagy via the Wnt//β-catenin signal pathway. Cytokine. 136(155292)2020.PubMed/NCBI View Article : Google Scholar